|  | Before PS matching | After PS matching |  | ||||
---|---|---|---|---|---|---|---|---|
Covariate | TKA | UKA | SMD | p-value | TKA | UKA | SMD | p-value |
n | 228,595 | 30,724 | Â | Â | 30,591 | 30,591 | Â | Â |
Sex | ||||||||
Men | 47,839 (20.9%) | 8487 (27.6%) | 0.16 | < 0.0001* | 7932 (26.0%) | 8459 (27.6%) | 0.039 | < 0.0001* |
Women | 180,756 (79.1%) | 22,237 (72.4%) | 22,659 (74.0%) | 22,132 (72.4%) | ||||
Age (years) | 74.8 ± 7.8 | 74.3 ± 7.6 | 0.056 | < 0.0001* | 74.4 ± 7.7 | 74.3 ± 7.6 | 0.009 | 0.28 |
Body mass index | 26.2 ± 4.9 | 25.3 ± 3.6 | 0.19 | < 0.0001* | 25.2 ± 3.8 | 25.3 ± 3.6 | 0.012 | 0.13 |
Hypertension | 81,559 (35.7%) | 9894 (32.2%) | 0.073 | < 0.0001* | 9573 (31.3%) | 9861 (32.2%) | 0.02 | 0.012 |
Diabetes | 49,373 (21.6%) | 5801 (18.9%) | 0.068 | < 0.0001* | 5420 (17.7%) | 5783 (18.9%) | 0.031 | 0.0001* |
Cerebrovascular disease | 7419 (3.3%) | 879 (2.9%) | 0.022 | 0.0003* | 804 (2.6%) | 877 (2.9%) | 0.015 | 0.071 |
Ischemic heart disease | 13,615 (6.0%) | 1671 (5.4%) | 0.022 | 0.0003* | 1545 (5.0%) | 1663 (5.4%) | 0.017 | 0.032 |
Chronic renal dysfunction | 6438 (2.8%) | 698 (2.3%) | 0.035 | < 0.0001* | 603 (2.0%) | 696 (2.3%) | 0.021 | 0.009* |
Chronic lung disease | 1350 (0.6%) | 137 (0.5%) | 0.02 | 0.0016* | 117 (0.4%) | 137 (0.4%) | 0.01 | 0.21 |
Cognitive impairment | 3594 (1.6%) | 373 (1.2%) | 0.031 | < 0.0001* | 345 (1.1%) | 372 (1.2%) | 0.008 | 0.31 |
Hyperlipidemia | 45,250 (19.8%) | 6087 (19.8%) | 0.0004 | 0.94 | 5728 (18.7%) | 6053 (19.8%) | 0.027 | 0.0009* |
Rheumatic disease | 9105 (4.0%) | 394 (1.3%) | 0.18 | < 0.0001* | 423 (1.4%) | 391 (1.3%) | 0.009 | 0.26 |
Bilateral surgery | 15,375 (6.7%) | 1275 (4.2%) | 0.11 | < 0.0001* | 1094 (3.6%) | 1274 (4.2%) | 0.03 | 0.0002* |
Non-covariate | TKA | UKA | F value or χ2 statistics | p-value | TKA | UKA | F value or χ2 statistics | p-value |
Charlson Comorbidity Index | 0.70 ± 0.95 | 0.54 ± 0.85 | 850.7 | < 0.0001* | 0.61 ± 0.89 | 0.54 ± 0.85 | 101.7 | < 0.0001* |
Glucocorticoid use | 6136 (2.7%) | 341 (1.1%) | 275.6 | < 0.0001* | 715 (2.3%) | 340 (1.1%) | 135.6 | < 0.0001* |
Length of hospitalization (days) | 28.6 ± 15.9 | 22.9 ± 11.5 | 3666 | < 0.0001* | 28.3 ± 14.7 | 22.9 ± 11.5 | 2515 | < 0.0001* |
Mortality during hospitalization | 104 (0.05%) | 10 (0.03%) | 1.0 | 0.31 | 15 (0.05%) | 10 (0.03%) | 1.0 | 0.32 |
Blood transfusion day 0 (unit) | 0.06 ± 0.42 | 0.006 ± 0.12 | 531.0 | < 0.0001* | 0.05 ± 0.40 | 0.006 ± 0.12 | 425.5 | < 0.0001* |
Blood transfusion day 1 (unit) | 0.04 ± 0.30 | 0.002 ± 0.07 | 395.6 | < 0.0001* | 0.03 ± 0.28 | 0.002 ± 0.07 | 332.7 | < 0.0001* |
Bone cement use | 206,532 (90.4%) | 29,003 (94.4%) | 533.3 | < 0.0001* | 27,721 (90.6%) | 28,874 (94.4%) | 313.3 | < 0.0001* |
Navigation use | 65,889 (28.8%) | 8096 (26.4%) | 81.2 | < 0.0001* | 8807 (28.8%) | 8058 (26.3%) | 45.9 | < 0.0001* |